Quadrant Capital Group’s BioXcel Therapeutics BTAI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-53	Closed	-$15.8K	–	2700
2023 Q1	$15.8K	Buy	+53	New	+$15.8K	﹤0.01%	1816
2022 Q4	–	Sell	-8	Closed	-$2K	–	2748
2022 Q3	$2K	Buy	+8	New	+$2K	﹤0.01%	2344